NCT04106778View on ClinicalTrials.gov

DMT310-003 Topical in the Treatment of Acne Vulgaris

PHASE2CompletedINTERVENTIONAL
Enrollment

181

Participants

Timeline

Start Date

October 10, 2019

Primary Completion Date

May 4, 2020

Study Completion Date

May 4, 2020

Conditions
Acne Vulgaris
Interventions
DRUG

DMT310

Topical Powder

DRUG

Placebo

Placebo Topical Powder

Trial Locations (1)

78759

Dermata Investigational Site, Austin

Sponsors
All Listed Sponsors
lead

Dermata Therapeutics

INDUSTRY

NCT04106778 - DMT310-003 Topical in the Treatment of Acne Vulgaris | Biotech Hunter | Biotech Hunter